Countries covered: Global
The global generic drug market is estimated to be between $19 and $22 billion, with compound growth of 11%-12% annually.
According to the U.S. Congressional Budget Office, generic drugs save consumers an estimated $8 to $10 billion per year at retail pharmacies. Even more billions are saved when hospitals use generics.
In order to help your organization make educated decisions in this rapidly expanding market, Theta’s study is designed to provide the reader with an overall view of generic drugs, their manufacturers, market figures, competitor market shares, recent and upcoming approvals, issues affecting the market and other valuable information.
Product segments covered in this report include:
- Anti-Infectives
- Cancer Drugs
- Cardiovascular Drugs
- Central Nervous System Drugs
- Gastrointestinal Drugs
- Hormone, Endocrine, and Metabolic Disease Drugs
- Respiratory Drugs and Allergy Treatments
Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.
Related Reports:
Snapshots US Pharmaceuticals 2009
Pharmaceutical Industry in Mexico
Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
Pharmaceuticals Industry Report
Antipsychotics Market Forecast
Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
Prescription Drug Wholesaling in the US - Industry Risk Rating Report
Antidepressants Market Forecast
Snapshots Australia Pharmaceuticals 2009
Snapshots Bulgaria Pharmaceuticals 2009
|
(0 items)
